Skip to main content
Equibles

Cormorant Asset Management, LP

Position in ABVX — Abivax S.A.

CIK 1583977 BOSTON, MA
Back to ABVX Full portfolio

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$89,950,500
+$5,324,500 QoQ
Shares Held
675,000
-11.2% QoQ
Ownership
0.774%
of shares outstanding
% of Portfolio
4.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. ABVX ranks #9 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 640,000 $214,265,600
2 BBOT
BridgeBio Oncology Therapeutics, Inc.
 17,878,594 $136,234,886
3 PBLS
Parabilis Medicines, Inc.
 4,615,612 $126,329,300
4 RAPP
Rapport Therapeutics, Inc.
 2,657,521 $110,738,900
5 ERAS
Erasca, Inc.
 6,000,000 $109,920,000
6 EWTX
Edgewise Therapeutics, Inc.
 2,510,000 $101,981,300
7 EYPT
EyePoint, Inc.
 7,000,000 $100,100,000
8 ALMS
Alumis Inc.
 3,285,596 $92,456,671

All Filings in ABVX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,950,500 675,000
2026-03-31 $84,626,000 760,000
2025-12-31 $182,054,250 1,350,000
2025-09-30 $165,555,000 1,950,000
2025-06-30 $16,294,500 2,130,000
2025-03-31 $13,312,500 2,130,000
2024-12-31 $15,591,600 2,130,000
2024-09-30 $24,537,600 2,130,000
2024-06-30 $28,158,600 2,130,000
2024-03-31 $30,459,000 2,130,000
2023-12-31 $22,791,000 2,130,000